Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the Molecular Interaction Between the Adhesion G Protein-Coupled Receptor ADGRV1 and its PDZ-Containing Regulator PDZD7. | Front Mol Biosci | 2022 | 35836927 | PubTator, text mining | PubMed |
| Genetics of Inherited Retinal Diseases in Understudied Ethnic Groups in Italian Hospitals. | Front Genet | 2022 | 35836572 | PubTator, text mining | PubMed |
| Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene. | Nucleic Acid Ther | 2022 | 35833796 | PubTator, text mining | PubMed |
| Whole-exome sequencing identified genes known to be responsible for retinitis pigmentosa in 28 Chinese families. | Mol Vis | 2022 | 35814500 | PubTator, text mining | PubMed |
| A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments. | J Thorac Dis | 2022 | 35813746 | PubTator, text mining | PubMed |
| ADGRV1 Variants in Febrile Seizures/Epilepsy With Antecedent Febrile Seizures and Their Associations With Audio-Visual Abnormalities. | Front Mol Neurosci | 2022 | 35813073 | PubTator, text mining | PubMed |
| Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer. | Front Immunol | 2022 | 35812403 | PubTator, text mining | PubMed |
| Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation. | Int J Mol Sci | 2022 | 35806438 | PubTator, text mining | PubMed |
| The Clinical Spectrum and Disease Course of DRAM2 Retinopathy. | Int J Mol Sci | 2022 | 35806404 | PubTator, text mining | PubMed |
| Dysregulated Immune and Metabolic Microenvironment Is Associated with the Post-Operative Relapse in Stage I Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 35804832 | PubTator, text mining | PubMed |
| Retinitis pigmentosa in Usher syndrome in India: Electronic medical records driven big data analytics: Report III. | Indian J Ophthalmol | 2022 | 35791152 | PubTator, text mining | PubMed |
| Genetic dissection of non-syndromic retinitis pigmentosa. | Indian J Ophthalmol | 2022 | 35791117 | PubTator, text mining | PubMed |
| Commentary: CRISPR gene editing for inherited retinal dystrophies: Towards clinical translation. | Indian J Ophthalmol | 2022 | 35791113 | PubTator, text mining | PubMed |
| Newer therapeutic options for inherited retinal diseases: Gene and cell replacement therapy. | Indian J Ophthalmol | 2022 | 35791112 | PubTator, text mining | PubMed |
| Approach to inherited retinal diseases. | Indian J Ophthalmol | 2022 | 35791111 | PubTator, text mining | PubMed |
| Affinity purification of in vivo assembled whirlin-associated protein complexes from the zebrafish retina. | J Proteomics | 2022 | 35788411 | PubTator, text mining | PubMed |
| Cas-Based Systems for RNA Editing in Gene Therapy of Monogenic Diseases: In Vitro and in Vivo Application and Translational Potential. | Front Cell Dev Biol | 2022 | 35784464 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognostic value and immune implications of the TTK gene in lung adenocarcinoma: a meta-analysis and bioinformatics analysis. | Anim Cells Syst (Seoul) | 2022 | 35784389 | PubTator, text mining | PubMed |
| Combined Preimplantation Genetic Testing for Genetic Kidney Disease: Genetic Risk Identification, Assisted Reproductive Cycle, and Pregnancy Outcome Analysis. | Front Med (Lausanne) | 2022 | 35783601 | PubTator, text mining | PubMed |
| Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study. | Transl Oncol | 2022 | 35777247 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=33